Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA)

被引:247
作者
Brown, DFJ
Edwards, DI
Hawkey, PM
Morrison, D
Ridgway, GL
Towner, KJ
Wren, MWD
机构
[1] Addenbrookes Hosp, Hlth Protect Agcy, Cambridge CB2 2QW, England
[2] Univ Birmingham, Birmingham B9 2TT, W Midlands, England
[3] Heartlands Hosp, Birmingham B5 9SS, W Midlands, England
[4] Stobhill Hosp, Scottish MRSA Reference Lab, Dept Microbiol, Glasgow G21 3UW, Lanark, Scotland
[5] Dept Hlth, London SE1 8UG, England
[6] Univ Hosp, Queens Med Ctr, Dept Microbiol, Nottingham NG7 2UH, England
[7] UCL Hosp, Windeyer Inst Med Sci, Dept Clin Microbiol, London W1T 4JF, England
关键词
MRSA identification; MRSA susceptibility testing; MRSA screening; MRSA molecular methods; GISA; meticillin;
D O I
10.1093/jac/dki372
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
These evidence-based guidelines have been produced after a literature review of the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). We have considered the detection of MRSA in screening samples and the detection of reduced susceptibility to glycopeptides in S. aureus. Recommendations are given for the identification of S. aureus and for suitable methods of susceptibility testing and screening for MRSA and for S. aureus with reduced susceptibility to glycopeptides. These guidelines indicate what tests should be used but not when the tests are applicable, as aspects of this are dealt with in guidelines on control of MRSA. There are currently several developments in screening media and molecular methods. It is likely that some of our recommendations will require modification as the new methods become available.
引用
收藏
页码:1000 / 1018
页数:19
相关论文
共 196 条
  • [1] Acar J F, 1970, Antimicrob Agents Chemother (Bethesda), V10, P280
  • [2] BSAC standardized disc susceptibility testing method (version 3)
    Andrews, JM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) : 713 - 728
  • [3] Annear D I, 1968, Med J Aust, V1, P444
  • [4] [Anonymous], 1961, BMJ-BRIT MED J, V1, P113
  • [5] [Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P902
  • [6] [Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P565
  • [7] [Anonymous], J HOSP INFECT
  • [8] Performance of a new chromogenic oxacillin resistance screen medium (Oxoid) in the detection and presumptive identification of methicillin-resistant Staphylococcus aureus
    Apfalter, P
    Assadian, O
    Kalczyk, A
    Lindenmann, V
    Makristathis, A
    Mustafa, S
    Rotter, M
    Hirschl, AM
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 44 (02) : 209 - 211
  • [9] Where has vancomycin-heterogeneously resistant Staphylococcus aureus gone?
    Arakawa, Y
    Ike, Y
    Nagasawa, M
    [J]. LANCET, 2004, 363 (9418) : 1401 - 1401
  • [10] Comparison of the Velogene Rapid MRSA Identification Assay, Denka MRSA-Screen Assay, and BBL Crystal MRSA ID system for rapid identification of methicillin-resistant Staphylococcus aureus
    Arbique, J
    Forward, K
    Haldane, D
    Davidson, R
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 40 (1-2) : 5 - 10